KCM
Kanawha Capital Management Portfolio holdings
AUM
$1.35B
1-Year Return
17.04%
This Quarter Return
+4.07%
1 Year Return
+17.04%
3 Year Return
+54.17%
5 Year Return
+102.49%
10 Year Return
+216.88%
AUM
$595M
AUM Growth
-$1.12M
(-0.19%)
Cap. Flow
-$19.5M
Cap. Flow
% of AUM
-3.27%
Top 10 Holdings %
Top 10 Hldgs %
23.92%
Holding
167
New
3
Increased
15
Reduced
116
Closed
3
Top Buys
| 1 |
Nike
NKE
|
+$1.63M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$658K |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
+$385K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$285K |
| 5 |
Phillips 66
PSX
|
+$210K |
Top Sells
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$736K |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$676K |
| 3 |
Apple
AAPL
|
+$631K |
| 4 |
Lowe's Companies
LOW
|
+$613K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$569K |
Sector Composition
| 1 | Industrials | 13% |
| 2 | Technology | 12.7% |
| 3 | Financials | 12.58% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Staples | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Union Pacific
UNP
$128B
| $241K | 0.04% |
2,329
-800
| -26% | -$82.8K |
|
152
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.8B
| $227K | 0.04% |
2,792
-2,410
| -46% | -$196K |
|
153
Novartis
NVS
$248B
| $226K | 0.04% |
3,460
| – | – |
|
154
Bank of America
BAC
$372B
| $222K | 0.04% |
10,043
-2,528
| -20% | -$55.9K |
|
155
ITT
ITT
$13.4B
| $216K | 0.04% |
5,595
-1,100
| -16% | -$42.5K |
|
156
iShares MSCI Japan ETF
EWJ
$15.7B
| $213K | 0.04% |
4,363
-1
| -0% | -$49 |
|
|
157
Phillips 66
PSX
$53.5B
| $210K | 0.04% |
+2,427
| New | +$210K |
|
158
Hormel Foods
HRL
$14B
| $209K | 0.04% |
6,014
| – | – |
|
159
Invesco S&P 500 Equal Weight ETF
RSP
$74.2B
| $209K | 0.04% |
2,410
| – | – |
|
160
SPDR Gold Trust
GLD
$115B
| $201K | 0.03% |
1,830
| – | – |
|
161
Tidewater
TDW
$2.89B
| $110K | 0.02% |
1,000
-433
| -30% | -$47.6K |
|
162
iShares Russell 1000 ETF
IWB
$44.1B
| – | – |
-3,065
| Closed | -$369K |
|
163
Macy's
M
$4.61B
| – | – |
-7,875
| Closed | -$292K |
|
164
Teva Pharmaceuticals
TEVA
$22.6B
| – | – |
-4,460
| Closed | -$205K |
|